Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1991-5-30
|
| pubmed:abstractText |
The failure so far of the clinical effort to exploit laboratory knowledge as to the importance of hypoxia as a cause for radiation failure may have been the pursuit of this approach in isolation from other causes for radioresistance. In particular a capacity for rapid repopulation may be shown by a tumour showing resistance due to hypoxia. A knowledge of all the factors affecting radiosensitivity is required before the rational testing of hypoxic cell sensitisers can be planned.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0167-8140
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
20 Suppl 1
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
9-11
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1991
|
| pubmed:articleTitle |
Hypoxia and local tumour control. Part 2.
|
| pubmed:affiliation |
Marie Curie Research Wing, Regional Centre for Radiotherapy and Oncology, Mount Vernon Hospital, Northwood, Middlesex, U.K.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|